Overview

Determination of Carboplatin's Optimal Plasmatic Exposure

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
To determine Carboplatin's optimal exposures(optimal AUCs)and parameters they depend on.
Phase:
N/A
Details
Lead Sponsor:
Institut Claudius Regaud
Treatments:
Carboplatin